بدائل البحث:
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
significant a » significant _ (توسيع البحث), significant gap (توسيع البحث), significant all (توسيع البحث)
significant i » significant _ (توسيع البحث), significant co (توسيع البحث), significant 17 (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
significant a » significant _ (توسيع البحث), significant gap (توسيع البحث), significant all (توسيع البحث)
significant i » significant _ (توسيع البحث), significant co (توسيع البحث), significant 17 (توسيع البحث)
-
201
-
202
-
203
-
204
-
205
-
206
-
207
-
208
-
209
HDECO: A method for Decreasing energy and cost by using virtual machine migration by considering hybrid parameters
منشور في 2025"…<h2>Summary</h2><p dir="ltr">This research introduces <b>HDECO</b> (Hybrid Decreasing Energy and Cost Optimization) — a method designed to reduce both energy consumption and execution cost in cloud datacenters through intelligent virtual machine migration. …"
-
210
-
211
-
212
-
213
-
214
-
215
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
منشور في 2025"…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …"
-
216
-
217
-
218
Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations.
منشور في 2025"…<p><b>(A)</b> A significant reduction in colony-forming ability was observed in U87MG cells treated with 100ΜM SHG-44 compared to 100ΜM cis-platin and the untreated control. …"
-
219
-
220
Presentation 1_Prehospital tranexamic acid decreases early mortality in trauma patients: a systematic review and meta-analysis.pdf
منشور في 2025"…Compared to the control group, the prehospital TXA group exhibited a significant reduction in 24-h mortality with an OR of 0.72 and a 95% CI of 0.54–0.94 (p = 0.02), while no statistically significant difference in the incidence of venous thromboembolism (VTE; OR: 1.14, 95% CI: 0.98–1.33, p = 0.09). …"